logo

TIL

Instil Bio·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural

Instil Bio's fundamentals score 5.8/10, indicating moderate health. Strengths include favorable PB-ROE and Asset-MV factors, but concerns arise from Net profit / Total profit at 100% and a negative Revenue-MV reading. This combination points to solid asset efficiency and profitability relative to book value, yet raises questions about revenue scaling and profit composition, warranting a cautious stance.

Fundamental(5.75)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score1/3
Weight9.19%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight8.07%
1M Return5.26%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.71%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight13.76%
1M Return7.79%
PB-ROE
Value-0.50
Score3/3
Weight21.61%
1M Return11.47%
Current assets turnover ratio
Value1.78
Score2/3
Weight1.61%
1M Return1.15%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.17%
1M Return0.86%
Asset-MV
Value-0.50
Score3/3
Weight31.93%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight13.78%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Is TIL fundamentally strong?
  • TIL scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its -43.59% ROE, 0.00% net margin, -0.70 P/E ratio, 0.44 P/B ratio, and 1.82% earnings growth, these metrics solidify its Netural investment rating.